Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors

Radiotherapy is routinely used as a neoadjuvant, adjuvant or palliative treatment in various cancers. There is significant variation in clinical response to radiotherapy with or without traditional chemotherapy. Patients with a good response to radiotherapy demonstrate better clinical outcomes unive...

Descripción completa

Detalles Bibliográficos
Autores principales: Wanigasooriya, Kasun, Tyler, Robert, Barros-Silva, Joao D., Sinha, Yashashwi, Ismail, Tariq, Beggs, Andrew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281073/
https://www.ncbi.nlm.nih.gov/pubmed/32443649
http://dx.doi.org/10.3390/cancers12051278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281073/
https://www.ncbi.nlm.nih.gov/pubmed/32443649
http://dx.doi.org/10.3390/cancers12051278

Ejemplares similares